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High-resolution PET imaging, with the dedicated small an-
imal PET tomograph quad-HIDAC (Oxford Positron Sys-
tems, UK), of Caki-2 renal cell carcinoma xenografts with
64Cu-CPTA-labelled mAb chCE7. A nude mouse (26 g)
with Caki-2 renal cell carcinoma tumours on the right and
left sides was injected with 21 MBq (27 µg) 64Cu-CPTA-
chCE7 and data were acquired for 70 min at 26.5 h post in-
jection. The reconstructed images represent a series of co-
ronal slices (0.3 mm thickness) from ventral (1) to dorsal
(12) (T, tumour; L, lymph node). Strong uptake is observed
in two subcutaneous tumour xenografts on the back of the
mouse (Table 1, and T in coronal sections 7–12). Lower
levels of activity are also demonstrated in other organs: the
liver and the spleen (sections 1–6), as well as lymph nodes
(submandibular and parotid lymph nodes: sections 1 and 2;
suprascapular and supraclavicular lymph nodes: sections
3–5; and deep inguinal lymph nodes: sections 6–8). The 
renal cell tumours do not metastasise, and as the chCE7
antibody does not react with mouse L1-CAM, the accumu-
lation is not due to specific target cell binding. Accumula-
tion of radioactivity in the lymph nodes is higher than in
the liver and spleen and is likely to be due to radiocopper
labelled metabolites accumulating in cells of the reticulo-
endothelial system present in lymph nodes.
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Table 1. Uptake of 67Cu-CPTA-labelled mAb chCE7 (185 kBq/
5 µg) in Caki-2 renal carcinoma xenografts and normal tissues
24 h post injection in groups of three cd/nu mice. Data are repre-
sented as % injected dose/g of mouse weight (%ID/g)±1SD
Tissue % ID/g 24 h p.i.
Blood 9.7±5.0
Heart 5.2±1.8
Spleen 9.3±3.3
Kidney 5.0±0.9
Stomach 0.6±0.2
Intestine 1.9±0.4
Liver 7.2±0.8
Muscle 2.3±0.5
Tumour 18.8±4.3
